Resources

Publications

  • 11.11.2020  |  The Lancet – COVID-19 pneumonia and the appropriate use of antibiotics Download
  • 10.23.2020  |  Nature – Improving data sharing to increase the efficiency of antibiotic R&D Download
  • 10.11.2020  |  United States National Action Plan for Combating Antibiotic-Resistant Bacteria, 2020-2025 Download
  • 06.25.2020  |  Clinical Infectious Diseases – Antibacterial R&D at a crossroads: We’ve pushed as hard as we can … now we need to start pulling! Download
  • 06.19.2020  |  Innovation in Antimicrobial Resistance: The CARB-X Perspective Download
  • 06.01.2020  |  Translational Research – Evaluating for-profit public benefit corporations as an additional structure for antibiotic development and commercialization Download
  • 04.30.2020  |  A One Health framework to estimate costs of antimicrobial resistance Download
  • 04.20.2020  |  Lancet Infectious Diseases – The Lancet Infectious Diseases Commission on antimicrobial resistance: 6 years later Download
  • 01.30.2020  |  Clinical Infectious Diseases – Antibiotic development incentives that reflect societal value of antibiotics Download
  • 11.19.2019  |  Nature Microbiology – The global preclinical antibacterial pipeline Download
  • 11.19.2019  |  Nature Microbiology – Antibiotic development – economic, regulatory and societal challenges Download
  • 10.30.2019  |  Lancet – A roadmap for sustainably governing the global antimicrobial commons Download
  • 10.02.2019  |  Nature Biotechnology – A shot in the arm for new antibiotics Download
  • 07.31.2019  |  Nature Communications – Designing development programs for non-traditional antibacterial agents Download
  • 10.16.2018  |  PLOS ONE – Introduction and geographic availability of new antibiotics approved between 1999 and 2014 Download
  • 10.01.2018  |  US National Action Plan for Combating Antibiotic-Resistant Bacteria: Progress Report: Year 3 – US Government CARB Task Force | Task Force provides an update on progress it is making on its 2015 commitment to slow the emergence of resistant bacteria and prevent the spread of resistant infections, strengthen national one-health surveillance, advance development and use of rapid diagnostic tests and characterization of resistant bacteria, accelerate basic and applied R&D for new antibiotics and other therapeutics, and improve international collaboration for prevention, surveillance, control and R&D. Download
  • 07.17.2018  |  Journal of Law, Medicine, & Ethics – A Perspective on Incentives for Novel Inpatient Antibiotics: No One-Size-Fits-All Download
  • 06.22.2018  |  World Economic Forum report in collaboration with Wellcome Trust: Not enough new antibiotics are in development to guarantee that we can continue to treat infections. This briefing outlines why pull incentives are necessary in addition to push funding, some of the key challenges they need to address and next steps towards implementing or piloting a pull incentive. Download
  • 04.05.2018  |  J Pharm Policy Pract – Insights into early stage of antibiotic development in small- and medium-sized enterprises: a survey of targets, costs, and durations Download
  • 01.15.2018  |  Drive-AB Report: Revitalizing the antibiotic pipeline Download
  • 01.10.2018  |  Qualified Infectious Disease Product Designation Questions and Answers Guidance for Industry Download
  • 11.21.2017  |  Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis Download
  • 11.16.2017  |  BEAM Alliance Position Paper 2017 Key Guidelines to implement effective measures toward SMEs to revive the antibacterial R&D field Download
  • 11.01.2017  |  Global Framework for Development & Stewardship to Combat Antimicrobial Resistance – Roadmap Download
  • 10.24.2017  |  The Antibiotic Future Download
  • 10.17.2017  |  The Value Added of the United Nations General Assembly High–Level Political Declaration on Antimicrobial Resistance Download
  • 10.06.2017  |  Innovation in the preclinical antibiotic pipeline Download
  • 09.08.2017  |  Disproportionate Exposure to Antibiotics in Children at Risk for Invasive Pneumococcal Disease: Potential for Emerging Resistance and Opportunity for Antibiotic Stewardship Download
  • 07.01.2017  |  Antimicrobial resistance inWest Africa: a systematic review and meta-analysis Download
  • 06.06.2017  |  To the G20: incentivising antibacterial research and development Download
  • 05.15.2017  |  Incentives for New Drugs to Tackle Anti-Microbial Resistance Download
  • 04.23.2017  |  We Will Miss Antibiotics When They’re Gone Download
  • 03.15.2017  |  Antibiotic Resistance: More Information Needed to Oversee Use of Medically Important Drugs in Food Animals (GAO) Download
  • 02.03.2017  |  Berlin Declaration of the G20 Health Ministers Download
  • 02.03.2017  |  G20/OECD Focus Group Meeting on Antimicrobial Resistance Download
  • 12.01.2016  |  Economic Incentives for Antibacterial Drug Development: Literature Review and Considerations From the Transatlantic Task Force on Antimicrobial Resistance Download
  • 08.12.2016  |  Linking sustainable use policies to novel economic incentives to stimulate antibiotic research and development Download
  • 07.29.2016  |  Accelerating global innovation to address antibacterial resistance: introducing CARB-X Download
  • 06.14.2016  |  Delinking Investment in Antibiotic Research and Development from Sales Revenues: The Challenges of Transforming a Promising Idea into Reality. Download
  • 05.31.2016  |  Progress in the Fight Against Multidrug-Resistant Bacteria? A Review of U.S. Food and Drug Administration–Approved Antibiotics. Download
  • 05.15.2016  |  A Scientific Roadmap for Antibiotic Discovery Download
  • 05.15.2016  |  Funding Antibiotic Innovation With Vouchers: RecommendationsOn How To Strengthen A Flawed Incentive Policy Download
  • 11.18.2015  |  International cooperation to improve access to and sustain effectiveness of antimicrobials Download
  • 08.01.2015  |  What Will It Take to Address the Global Threat of Antibiotic Resistance? Download
  • 08.01.2015  |  Antibiotic Resistance: Journal of American Society of Law, Medicine & Ethics Download
  • 06.01.2015  |  Responding to the Threat of Antimicrobial Resistance Download
  • 02.26.2015  |  Repairing the Broken Market for Antibiotic Innovation Download
  • 02.01.2015  |  An international legal framework to address antimicrobial resistance Download
  • 02.01.2015  |  Business Model Options for Antibiotics – Learning from Other Industries Download
  • 04.14.2014  |  Analytical Framework for Examining the Value of Antibacterial Products Download
  • 02.15.2014  |  New Business Models for Sustainable Antibiotics Download
  • 02.15.2012  |  Combating Antibiotic Resistance Through The Health Impact Fund Download
  • 05.11.2011  |  Germ Shed Management in the United States Download
  • 01.15.2011  |  Challenges of Antibacterial Discovery Download
  • 11.20.2010  |  Improving antibiotic markets for long term stability Download
  • 11.15.2010  |  Superbugs call for super changes in drug-sale rules Download
  • 09.01.2010  |  Fighting Antibiotic Resistance: Marrying New Financial Incentives To Meeting Public Health Goals Download
  • 08.01.2007  |  Will longer antimicrobial patents improve public health? Download